Clinical Research, Pharma & Healthcare FinancingOwkin doses first patient in AI-optimized trial of OKN4395.Business WireJanuary 30, 2025February 21, 2025 by Business WireJanuary 30, 2025February 21, 2025078 Owkin, the first end-to-end AI-biotech that uses agentic AI to revolutionize drug discovery, development, and diagnostics, today announced that the first patient has been dosed...
